000 01387 a2200385 4500
005 20250517204909.0
264 0 _c20180501
008 201805s 0 0 eng d
022 _a1479-683X
024 7 _a10.1530/EJE-17-1072
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRussell, Nicholas
245 0 0 _aShort-term effects of transdermal estradiol in men undergoing androgen deprivation therapy for prostate cancer: a randomized placebo-controlled trial.
_h[electronic resource]
260 _bEuropean journal of endocrinology
_cMay 2018
300 _a565-576 p.
_bdigital
500 _aPublication Type: Journal Article; Randomized Controlled Trial
650 0 4 _aAdministration, Cutaneous
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAndrogen Antagonists
_xtherapeutic use
650 0 4 _aEstradiol
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aProstatic Neoplasms
_xblood
650 0 4 _aSingle-Blind Method
650 0 4 _aTreatment Outcome
700 1 _aHoermann, Rudolf
700 1 _aCheung, Ada S
700 1 _aChing, Michael
700 1 _aZajac, Jeffrey D
700 1 _aHandelsman, David J
700 1 _aGrossmann, Mathis
773 0 _tEuropean journal of endocrinology
_gvol. 178
_gno. 5
_gp. 565-576
856 4 0 _uhttps://doi.org/10.1530/EJE-17-1072
_zAvailable from publisher's website
999 _c28188671
_d28188671